Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heumann Pharma is a long-established German pharmaceutical company that specializes in the commercialization of generic medicinal products. Founded in 1913 by Ludwig Heumann, the company has built a significant presence in the German healthcare system, providing a wide range of affordable prescription and over-the-counter medications. Its extensive product portfolio addresses major therapeutic areas, including cardiovascular diseases, central nervous system disorders, and metabolic conditions. In 2005, Heumann Pharma was acquired by the Indian pharmaceutical group Torrent Pharmaceuticals, which integrated the company into its global supply chain. Today, Heumann Pharma operates as a key subsidiary, focusing on the distribution of high-quality generics to pharmacies and health insurance providers throughout Germany. The company is headquartered in Nuremberg and remains a trusted partner in the German statutory health insurance discount agreement system.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heumann Pharma Generica.